161 related articles for article (PubMed ID: 35672071)
1. Exploring the role of Microbiome in Susceptibility, Treatment Response and Outcome among Tuberculosis Patients from Pakistan: study protocol for a prospective cohort study (Micro-STOP).
Shahzad M; Andrews SC; Ul-Haq Z
BMJ Open; 2022 Jun; 12(6):e058463. PubMed ID: 35672071
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
[TBL] [Abstract][Full Text] [Related]
3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
4. Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study.
Marambire ET; Banze D; Mfinanga A; Mutsvangwa J; Mbunda TD; Ntinginya NE; Celso K; Kallenius G; Calderwood CJ; Geldmacher C; Held K; Appalarowthu T; Rieß F; Panzner U; Heinrich N; Kranzer K;
BMJ Open; 2022 Jul; 12(7):e060985. PubMed ID: 36427173
[TBL] [Abstract][Full Text] [Related]
5. Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study.
Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G
BMJ Open; 2021 Feb; 11(2):e042493. PubMed ID: 33593778
[TBL] [Abstract][Full Text] [Related]
6. A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol.
Brummaier T; Syed Ahamed Kabeer B; Lindow S; Konje JC; Pukrittayaamee S; Utzinger J; Toufiq M; Antoniou A; Marr AK; Suriyakan S; Kino T; Al Khodor S; Terranegra A; Nosten F; Paris DH; McGready R; Chaussabel D
BMJ Open; 2019 Jan; 9(1):e023417. PubMed ID: 30782707
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Alimentary and Respiratory Tracts in Health and disease (EARTH) research programme: a protocol for prospective, longitudinal, controlled, observational studies in children with chronic disease at an Australian tertiary paediatric hospital.
Coffey MJ; McKay IR; Doumit M; Chuang S; Adams S; Stelzer-Braid S; Waters SA; Kasparian NA; Thomas T; Jaffe A; Katz T; Ooi CY
BMJ Open; 2020 Apr; 10(4):e033916. PubMed ID: 32295774
[TBL] [Abstract][Full Text] [Related]
8. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
[TBL] [Abstract][Full Text] [Related]
9. Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol.
Susic D; Davis G; O' Sullivan AJ; McGovern E; Harris K; Roberts LM; Craig ME; Mangos G; Hold GL; El-Omar EM; Henry A
BMJ Open; 2020 Sep; 10(9):e040189. PubMed ID: 32933964
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and Immune Consequences of Antibiotic Related Microbiome Alterations during first-line Tuberculosis Treatment in Bamako, Mali.
Diallo D; Sun S; Somboro AM; Baya B; Kone A; Diarra B; Nantoume M; Koloma I; Diakite M; Holl J; Maiga AI; Seydi M; Theron G; Hou L; Fodor A; Maiga M
Res Sq; 2023 Aug; ():. PubMed ID: 37609282
[TBL] [Abstract][Full Text] [Related]
11. An open-label pilot trial of faecal microbiome transfer to restore the gut microbiome in anorexia nervosa: protocol.
Wilson BC; Derraik JGB; Albert BB; Leong KSW; Tweedie-Cullen RY; Creagh C; Depczynski M; Edwards T; Vatanen T; Thabrew H; Cutfield WS; O'Sullivan JM
BMJ Open; 2023 Jul; 13(7):e070616. PubMed ID: 37429676
[TBL] [Abstract][Full Text] [Related]
12. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T
BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078
[TBL] [Abstract][Full Text] [Related]
13. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
Hurych J; Vejmelka J; Hlinakova L; Kramna L; Larionov V; Kulich M; Cinek O; Kohout P
BMJ Open; 2022 Jun; 12(6):e056594. PubMed ID: 35760542
[TBL] [Abstract][Full Text] [Related]
14. Burden of Drug resistant Tuberculosis in newly diagnosed Tuberculosis patients of Khyber Pakhtunkhwa, Pakistan.
Jabbar A; Khan TA; Rehman H; Khan AS; Ahmad S; Khan SN
J Pak Med Assoc; 2021 Mar; 71(3):912-915. PubMed ID: 34057947
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.
Ahmad T; ; Khan M; Khan MM; Ejeta E; Karami M; Ohia C
Int J Mycobacteriol; 2017; 6(4):360-364. PubMed ID: 29171450
[TBL] [Abstract][Full Text] [Related]
16. Prospective multicentre cohort trial on acute appendicitis and microbiota, aetiology and effects of antimicrobial treatment: study protocol for the MAPPAC (Microbiology APPendicitis ACuta) trial.
Vanhatalo S; Munukka E; Sippola S; Jalkanen S; Grönroos J; Marttila H; Eerola E; Hurme S; Hakanen AJ; Salminen P;
BMJ Open; 2019 Sep; 9(9):e031137. PubMed ID: 31494621
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol.
Bieri U; Scharl M; Sigg S; Szczerba BM; Morsy Y; Rüschoff JH; Schraml PH; Krauthammer M; Hefermehl LJ; Eberli D; Poyet C
BMJ Open; 2022 Apr; 12(4):e061421. PubMed ID: 35437256
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
19. Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study.
Jiménez-Jorge S; Labrador-Herrera G; Rosso-Fernández CM; Rodríguez-Torres N; Pachón-Ibáñez ME; Smani Y; Márquez-Malaver FJ; Limón Ramos C; Solano C; Vázquez-López L; Kwon M; Mora Barrios JM; Aguilar-Guisado M; Espigado I;
BMJ Open; 2020 Jul; 10(7):e034570. PubMed ID: 32690735
[TBL] [Abstract][Full Text] [Related]
20. Understanding the biology, morbidity and social contexts of adolescent tuberculosis: a prospective observational cohort study protocol (Teen TB).
Swanepoel J; Zimri K; van der Zalm MM; Hoddinott G; Palmer M; Doruyter A; De Beer G; Kleynhans L; Johnson SM; Jongen V; Wademan D; Mcimeli K; Jacobs S; Swanepoel R; Van Zyl G; Allwood BW; Malherbe S; Heuvelings C; Griffith-Richards S; Whittaker E; Moore DAJ; Schaaf HS; Hesseling AC; Seddon JA
BMJ Open; 2022 Dec; 12(12):e062979. PubMed ID: 36600434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
